The new location at Ebenezer Baptist Church is part of CVS Health's commitment to increase access to meaningful employment opportunities in underserved communities.
Semglee is both biosimilar to and interchangeable with Lantus, and is the first interchangeable biosimilar approved by the Food and Drug Administration.
Spiriva Handihaler had a market value of $1.5 billion for the 12 months ended May 2021, although actual generic market values are expected to be lower.